Dalacin-C 600mg Injection Vial

babies: consult your doctor. lactating mothers: it is likely to be safe to use in lactating mothers. studies have shown that it does not cause any harmful effects to the baby.
consult your doctor if you observe diarrhoea in the child. pregnancy: it is likely to be safe to use in pregnancy. even though limited human studies are available, animal studies have shown that it does not cause any or less harmful effects to the baby. driving: it is safe to use this medication while driving. alcohol: it is safe to consume alcohol with this medication. kidney: it should be used with caution in patients with kidney disease.
seek a doctor’s advice before using this medication. you may need a dose adjustment. liver: it should be used with caution in patients with liver disease.
seek a doctor’s advice before using this medication. you may need a dose adjustment..

pseudomembranous colitis maculopapular rash thrombophlebitis stomach pain nausea vomiting diarrhoea.

dalacin c is a macrolide class of medication. dalacin c stops bacterial growth and prevents the extent of infection by intervening with protein synthesis that is necessary for bacteria..

consult your doctor immediately if you missed the dose of dalacin c injection..

• this injection is used in the treatment of bacterial infections. it also helps to reduce symptoms associated with a bacterial infection • your doctor will administer this medication through the muscular or veins route • do not discontinue this medication as it may worsen your condition • tell your doctor if you experience diarrhoea even after the completion of treatment.
notify your doctor if you find blood in your stools • immediately inform your doctor if you experience any allergic reactions like an itchy rash, swelling of the face, throat, or tongue, or breathing difficulties while using this medication.

moderate • atracurium + dalacin c: concurrent use of these medications may result in prolonged neuromuscular blockade • cyclosporine + dalacin c: concurrent use of these medications may result in decreased bioavailability of cyclosporine • gallamine + dalacin c: concurrent use of these medications may result in prolonged neuromuscular blockade • metocurine + dalacin c: concurrent use of these medications may result in prolonged neuromuscular blockade • rocuronium + dalacin c: concurrent use of these medications may result in prolonged neuromuscular blockade • pipecuronium + dalacin c: concurrent use of these medications may result in prolonged neuromuscular blockade • tubocurarine + dalacin c: concurrent use of these medications may result in prolonged neuromuscular blockade • vecuronium + dalacin c: concurrent use of these medications may result in prolonged neuromuscular blockade • mivacurium + dalacin c: concurrent use of these medications may result in prolonged neuromuscular blockade.